Carlsmed, Inc. (CARL) vs Rezolute, Inc. (RZLT)
A side-by-side comparison of Carlsmed, Inc. and Rezolute, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CARL
Carlsmed, Inc.
$14.86HealthcareDelayed quote: Oct 6, 2026, 12:59 PM EDT
RZLT
Rezolute, Inc.
$4.34HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — CARL vs RZLT
growth of $100 · dividends reinvested · last 1yCARL +5.5% (+5.5%/yr)RZLT -19.4% (-19.4%/yr)CARL compounded faster over this window
CARL RZLT
CARL vs RZLT: by the numbers
- •RZLT is the larger company ($418M vs $404M market cap).
- •Both run net losses; RZLT's is the smaller (0.00% vs -57.42% net margin).
Metrics side by side
Valuation
| Metric | CARL | RZLT |
|---|---|---|
| P/S ratio | 6.38 | N/A |
| P/B ratio | 4.80 | 4.15 |
Profitability
| Metric | CARL | RZLT |
|---|---|---|
| Gross margin | 76.63% | 0.00% |
| Operating margin | -61.09% | 0.00% |
| Net margin | -57.42% | 0.00% |
| ROE | -43.14% | -77.06% |
| ROIC | -36.54% | -81.80% |
Growth (annualized)
| Metric | CARL | RZLT |
|---|---|---|
| Total return CAGR (5Y) | N/A | -9.57% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.